Max Borsche
Biographic Data
| ID | 7788088 |
|---|---|
| NAME | Max Borsche |
| GIVEN NAMES | Max |
| FAMILY NAME | Borsche |
| SIGNATURE | BORSCHE M |
| AFFILIATIONS | University of Lübeck |
| ORCID | 0000-0002-9651-5986 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Spreading of Sars-CoV-2 among adult asylum seekers in refugee community shelters in Lübeck, Germany between 2020 and 2022
Refugees residing in shared accommodations represent a vulnerable group for SARS-CoV-2 infection and transmission. This increased vulnerability does not diminish over time. Initial doubts regarding vaccination are higher among refugees. While this reservation can be overcome, awareness work is paramount and has to start anew with any new refugee wave
Influence of non-pharmaceutical interventions during the Covid-19 pandemic on respiratory viral infections – a prospective population-based cohort study
Non-pharmaceutical interventions (NPI) have been proven successful in a population-based approach to protect from SARS-CoV-2 transmission during the COVID-19 pandemic. As a consequential-effect, a reduction in the spread of all respiratory viruses has been observed, but the primary factors behind this phenomenon have yet to be identified. We conducted a subgroup analysis of participants from the ELISA study, a prospective longitudinal cohort stud…
Protocol of the Luebeck longitudinal investigation of Sars-CoV-2 infection (Elisa) study – a prospective population-based cohort study
DRKS.de, German Clinical Trials Register (DRKS), Identifier: DRKS00023418 , Registered on 28 October 2020
No prominent works on this page.
Protocol of the Luebeck longitudinal investigation of Sars-CoV-2 infection (Elisa) study – a prospective population-based cohort study
DRKS.de, German Clinical Trials Register (DRKS), Identifier: DRKS00023418 , Registered on 28 October 2020
Influence of non-pharmaceutical interventions during the Covid-19 pandemic on respiratory viral infections – a prospective population-based cohort study
Non-pharmaceutical interventions (NPI) have been proven successful in a population-based approach to protect from SARS-CoV-2 transmission during the COVID-19 pandemic. As a consequential-effect, a reduction in the spread of all respiratory viruses has been observed, but the primary factors behind this phenomenon have yet to be identified. We conducted a subgroup analysis of participants from the ELISA study, a prospective longitudinal cohort stud…
Spreading of Sars-CoV-2 among adult asylum seekers in refugee community shelters in Lübeck, Germany between 2020 and 2022
Refugees residing in shared accommodations represent a vulnerable group for SARS-CoV-2 infection and transmission. This increased vulnerability does not diminish over time. Initial doubts regarding vaccination are higher among refugees. While this reservation can be overcome, awareness work is paramount and has to start anew with any new refugee wave
Cohort (3 works) · Cohort study (3 works) · Environmental health (3 works) · Immunology (3 works) · Internal Medicine (3 works) · Medicine (3 works) · Population (3 works) · COVID-19 epidemiological studies (2 works) · Disease (2 works) · Epidemiology (2 works)